Brian W Whitcomb1, Sunni L Mumford2, Neil J Perkins2, Jean Wactawski-Wende3, Elizabeth R Bertone-Johnson4, Kristine E Lynch4, Enrique F Schisterman2. 1. Division of Biostatistics and Epidemiology, University of Massachusetts, Amherst, Massachusetts. Electronic address: bwhitcomb@schoolph.umass.edu. 2. Division of Epidemiology, Statistics and Prevention Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland. 3. Department of Social and Preventive Medicine, State University of New York, Buffalo, New York. 4. Division of Biostatistics and Epidemiology, University of Massachusetts, Amherst, Massachusetts.
Abstract
OBJECTIVE: To assess the utility of urinary cytokines for monitoring reproductive function by considering detection, variation across the menstrual cycle, and relations with hormones. DESIGN: Longitudinal cohort study. SETTING: Academic institution. PATIENT(S): Healthy, reproductive-aged women with self-reported regular menstrual cycles and at least one observed ovulatory cycle (n = 248). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Urinary cytokines measured by 30-plex immunoassays in 3,550 biospecimens, and nested random-effects analysis of variance (ANOVA) and marginal structural models used to evaluate variability and relations with hormones. RESULT(S): For 24 of 30 evaluated factors, detectable levels were observed in at least 50% of urine samples. Interleukin-6 (IL-6), IL-8, IL-10, IL-15, granulocyte colony stimulating factor (G-CSF), hepatocyte growth factor (HGF), interferon-α (IFN-α), and RANTES (regulated upon activation normal T-cell expressed and secreted) levels varied significantly across the menstrual cycle. The proinflammatory factors IL-1β, IL-6, IL-8, and HGF were 1.5-3 times higher during menses than the late follicular phase. In marginal structural models, IL-1β, IL-6, IL-8 were associated with lower estradiol and progesterone concentrations. CONCLUSION(S): Variability during the menstrual cycle and correlations with reproductive hormone levels support a role of cytokines in the menstrual cycle; however, because of the limited variability for most cytokines considered, the utility of urine as a matrix for assessment of inflammation in menstrual cycle function appears limited for clinical purposes.
OBJECTIVE: To assess the utility of urinary cytokines for monitoring reproductive function by considering detection, variation across the menstrual cycle, and relations with hormones. DESIGN: Longitudinal cohort study. SETTING: Academic institution. PATIENT(S): Healthy, reproductive-aged women with self-reported regular menstrual cycles and at least one observed ovulatory cycle (n = 248). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Urinary cytokines measured by 30-plex immunoassays in 3,550 biospecimens, and nested random-effects analysis of variance (ANOVA) and marginal structural models used to evaluate variability and relations with hormones. RESULT(S): For 24 of 30 evaluated factors, detectable levels were observed in at least 50% of urine samples. Interleukin-6 (IL-6), IL-8, IL-10, IL-15, granulocyte colony stimulating factor (G-CSF), hepatocyte growth factor (HGF), interferon-α (IFN-α), and RANTES (regulated upon activation normal T-cell expressed and secreted) levels varied significantly across the menstrual cycle. The proinflammatory factors IL-1β, IL-6, IL-8, and HGF were 1.5-3 times higher during menses than the late follicular phase. In marginal structural models, IL-1β, IL-6, IL-8 were associated with lower estradiol and progesterone concentrations. CONCLUSION(S): Variability during the menstrual cycle and correlations with reproductive hormone levels support a role of cytokines in the menstrual cycle; however, because of the limited variability for most cytokines considered, the utility of urine as a matrix for assessment of inflammation in menstrual cycle function appears limited for clinical purposes.
Authors: L Al-Harthi; D J Wright; D Anderson; M Cohen; D Matity Ahu; J Cohn; S Cu-Unvin; D Burns; P Reichelderfer; S Lewis; S Beckner; A Kovacs; A Landay Journal: J Interferon Cytokine Res Date: 2000-08 Impact factor: 2.607
Authors: K Yanagi; S Makinoda; R Fujii; S Miyazaki; S Fujita; H Tomizawa; K Yoshida; T Iura; T Takegami; T Nojima Journal: Hum Reprod Date: 2002-12 Impact factor: 6.918
Authors: Barbara L Andersen; Neha Godiwala Goyal; David M Weiss; Travis D Westbrook; Kami J Maddocks; John C Byrd; Amy J Johnson Journal: Cancer Date: 2018-05-14 Impact factor: 6.860
Authors: Rachel D Freed; Lushna M Mehra; Daniel Laor; Manishkumar Patel; Carmen M Alonso; Seunghee Kim-Schulze; Vilma Gabbay Journal: World J Biol Psychiatry Date: 2018-08-16 Impact factor: 4.132
Authors: Elizabeth R Bertone-Johnson; JoAnn E Manson; Alexandra C Purdue-Smithe; Susan E Hankinson; Bernard A Rosner; Brian W Whitcomb Journal: Menopause Date: 2019-01 Impact factor: 2.953
Authors: Sara Hurtado-Barroso; Paola Quifer-Rada; José Fernando Rinaldi de Alvarenga; Silvia Pérez-Fernández; Anna Tresserra-Rimbau; Rosa M Lamuela-Raventos Journal: Nutrients Date: 2018-11-14 Impact factor: 5.717